Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.
Turan RD, Tastan C, Dilek Kancagi D, Yurtsever B, Sir Karakus G, Ozer S, Abanuz S, Cakirsoy D, Tumentemur G, Demir S, Seyis U, Kuzay R, Elek M, Kocaoglu ME, Ertop G, Arbak S, Acikel Elmas M, Hemsinlioglu C, Hatirnaz Ng O, Akyoney S, Sahin I, Kayhan CK, Tokat F, Akpinar G, Kasap M, Kocagoz AS, Ozbek U, Telci D, Sahin F, Yalcin K, Ratip S, Ince U, Ovali E. Turan RD, et al. Among authors: ratip s. Sci Rep. 2021 Aug 4;11(1):15799. doi: 10.1038/s41598-021-95086-4. Sci Rep. 2021. PMID: 34349145 Free PMC article.
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates.
Sir Karakus G, Tastan C, Dilek Kancagi D, Yurtsever B, Tumentemur G, Demir S, Turan RD, Abanuz S, Cakirsoy D, Seyis U, Ozer S, Elibol O, Elek M, Ertop G, Arbak S, Acikel Elmas M, Hemsinlioglu C, Kocagoz AS, Hatirnaz Ng O, Akyoney S, Sahin I, Ozbek U, Telci D, Sahin F, Yalcin K, Ratip S, Ovali E. Sir Karakus G, et al. Among authors: ratip s. Sci Rep. 2021 Mar 11;11(1):5804. doi: 10.1038/s41598-021-83930-6. Sci Rep. 2021. PMID: 33707532 Free PMC article.
Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients.
Taştan C, Kançağı DD, Turan RD, Yurtsever B, Çakırsoy D, Abanuz S, Yılancı M, Seyis U, Özer S, Mert S, Kayhan CK, Tokat F, Açıkel Elmas M, Birdoğan S, Arbak S, Yalçın K, Sezgin A, Kızılkılıç E, Hemşinlioğlu C, İnce Ü, Ratip S, Ovalı E. Taştan C, et al. Among authors: ratip s. Turk J Haematol. 2020 Nov 19;37(4):234-247. doi: 10.4274/tjh.galenos.2020.2020.0070. Epub 2020 Aug 4. Turk J Haematol. 2020. PMID: 32755128 Free PMC article.
29 results